Semi-quantitative detection of viral RNA in influenza A virus-infected mice for evaluation of antiviral compounds

Antiviral Research

Volumn 58, Issue 1, 2003, Pages 81-87

  Sauerbrei, A ^a   Ulbricht, A ^a   Wutzler, P ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Antiviral compounds; Infection of respiratory tract; Influenza A virus; Mouse model; Reverse transcriptase polymerase chain reaction

Indexed keywords

ANTIVIRUS AGENT; VIRUS RNA; ZANAMIVIR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; EVALUATION; EXPERIMENTAL MODEL; INFLUENZA; INFLUENZA VIRUS A; LUNG; MALE; MOUSE; NASOPHARYNX; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE GENETICS; RESPIRATORY SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; SENSITIVITY ANALYSIS; TISSUE; TRACHEA; VIRAL GENETICS; VIRUS INHIBITION; VIRUS LOAD;

ANIMALS; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; DISEASE MODELS, ANIMAL; FEMALE; GUANIDINES; INFLUENZA A VIRUS; LUNG; MICE; MICE, INBRED BALB C; NASOPHARYNX; ORTHOMYXOVIRIDAE INFECTIONS; PYRANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SIALIC ACIDS; TRACHEA; ZANAMIVIR;

INFLUENZA A VIRUS; INFLUENZA VIRUS; MURINAE;

EID: 0037367291     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(02)00184-5     Document Type: Article

References (24)

1. Bantia S., Parker C.D., Ananth S.L., Horn L.L., Andries K., Chand P., Kotian P.L., Dehghani A., El-Kattan Y., Lin T., Hutchison T.L., Montgomery J.A., Kellog D.L., Babu Y.S. Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir. Antimicrob. Agents Chemother. 45:2001;1162-1167.
2. Barker S.M., Hoyle L. The nature of the toxic reaction of influenza virus towards lung tissue. J. Hyg. 70:1972;425-437.
3. Claas E.C.J., Sprenger M.J.W., Kleter G.E.M., van Beek R., Quint W.G.V., Masurel N. Type-specific identification of influenza viruses A, B and C by the polymerase chain reaction. J. Virol. Methods. 39:1992;1-13.
4. Dunn C.J., Goa K.L. Zanamivir: a review of its use in influenza. Drugs. 58:1999;761-784.
5. Fenton R.J., Morley P.J., Owens I.J., Gower D., Parry S., Crossman L., Wong T. Chemoprophylaxis of influenza A virus infections, with single doses of zanamivir, demonstrates that zanamivir is cleared slowly from the respiratory tract. Antimicrob. Agents Chemother. 43:1999;2642-2647.
6. Gubareva L.V., McCullers J.A., Bethell R.C., Webster R.G. Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice. J. Infect. Dis. 178:1998;1592-1596.
7. Hastings J.C., Selnick H., Wolanski B., Tomassini J.E. Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors. Antimicrob. Agents Chemother. 40:1996;1304-1307.
8. Liolios L., Jenney A., Spelman D., Kotsimbos T., Catton M., Wesselingh S. Comparison of a multiplex reverse transcription-PCR-enzyme hybridization assay with conventional viral culture and immunofluorescence techniques for the detection of seven viral respiratory pathogens. J. Clin. Microbiol. 39:2001;2779-2783.
9. Loosli C.G. The pathogenesis and pathology of experimental air-borne influenza virus A infections in mice. J. Infect. Dis. 84:1949;153-168.
10. McClellan K., Perry C.M. Oseltamivir: a review of its use in influenza. Drugs. 61:2001;263-283.
11. Mori I., Komatsu T., Takeuchi K., Nakakuki K., Sudo M., Kimura Y. Viremia induced by influenza virus. Microb. Pathog. 19:1995;237-244.
12. Novak M., Moldoveanu Z., Schafer D.P., Mestecky J., Compans R.W. Murine model for evaluation of protective immunity to influenza virus. Vaccine. 11:1993;55-60.
13. Ramphal R., Cogliano R.C., Shands J.W. Jr., Small P.A. Jr. Serum antibody prevents lethal murine influenza pneumonitis but not tracheitis. Infect. Immun. 25:1979a;992-997.
14. Ramphal R., Fischlschweiger R., Shands J.W. Jr., Small P.A. Jr. Murine influenzal tracheitis: a model for the study of influenza and tracheal epithelial repair. Am. Rev. Respir. Dis. 120:1979b;1313-1324.
15. Renegar K.B. Influenza virus infections and immunity: a review of human and animal models. Lab. Anim. Sci. 42:1992;222-232.
16. Renegar K.B., Johnson C.D., Dewitt R.C., King B.K., Li J., Fukatsu K., Kudsk K.A. Impairment of mucosal immunity by total parenteral nutrition: requirement for IgA in murine nasotracheal anti-influenza immunity. J. Immunol. 166:2001;819-825.
17. Ryan D.M., Ticehurst J., Dempsey M.H., Penn C.R. Inhibition of influenza virus replication in mice by GG167 (4-guanodino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase). Antimicrob. Agents Chemother. 38:1994;2270-2275.
18. Schulman J. Effect of L-amantanamine hydrochloride (amantadine HCl) and methyl-L-adamantanethylamine hydrochloride (rimantadine HCl) on transmission of influenza virus infection in mice. Proc. Soc. Exp. Biol. Med. 128:1968;1173-1178.
19. Sidwell, R.W., 1999. The mouse model of influenza virus infection. In: Zak, O., Sande, M.A. (Eds.), Handbook of Animal Models of Infection. Experimental Models in Antimicrobial Chemotherapy, Academic Press, San Diego, pp. 981-987.
20. Sidwell R.W., Smee D.F. In vitro and in vivo assay systems for study of influenza virus inhibitors. Antivir. Res. 48:2000;1-16.
21. Takano K., Jensen K.E., Warren J. Passive interferone protection in mouse influenza. Proc. Soc. Exp. Med. 114:1963;472-475.
22. Vu H.L., Troubetzkoy S., Nguyen H.H., Russell M.W., Mestecky J. A method for quantification of absolute amounts of nucleic acids by (RT)-PCR and a new mathematical model for data analysis. Nucleic Acids Res. 28:2000;E18.
23. Wyde P.R., Wilson S.Z., Gilbert B.E., Smith R.H.A. Protection of mice from lethal influenza virus infection with high dose-short duration ribavirin aerosol. Antimicrob. Agents Chemother. 30:1986;942-944.
24. Yetter R.A., Lehrer S., Ramphal R., Small P.A. Jr. Outcome of influenza infection: effect of site of initial infection and heterotypic immunity. Infect. Immun. 29:1980;654-662.